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Edited by Barry HalliwellAbstract Quercetin is a major ﬂavonoid in plant foods and
potentially has beneﬁcial eﬀects on disease prevention. The pres-
ent work demonstrated that quercetin was transported into the
lymph after being metabolized in the gastrointestinal mucosa
of rats. Glucuronide/sulfate and methylated conjugates of quer-
cetin appeared in the lymph, but not quercetin aglycone. The
highest lymphatic concentration was found at as rapid as
30 min after administration, suggesting gastric absorption,
whereas the mucosal glucuronidation activity was signiﬁcantly
higher in the duodenum and jejunum than in the stomach. This
is the ﬁrst report to show the lymphatic ﬂavonoid transport path-
way from the gastrointestinal tract.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Dietary ﬂavonoids have attracted much attention because of
the potentially beneﬁcial eﬀects on various disease prevention
[1–5]. Not only the function but also the bioavailability of
ﬂavonoids have been widely investigated in cell culture [6,7],
animal models [8,9] and in human volunteers [10–12]. It is well
known that the small intestine is one of the major tissues as
well as the liver to metabolize ﬂavonoids. Quercetin is a major
dietary ﬂavonoid found in high amounts in onions, apples, and
broccoli. Its metabolic pathway and plasma metabolites have
been well investigated among various ﬂavonoids.
Flavonoids are widely distributed in plant foods as glyco-
sidic derivatives in which one or more phenolic hydrogens
are substituted with sugar moieties. The type of sugar moiety
is a major determinant of ﬂavonoid absorption in the small
intestine [13,14]. While there are several glycosides that are ta-
ken up into the enterocyte via sodium glucose co-transporter 1
(SGLT1) [7,15,16], many glycosides need de-glycosylation to
be absorbed by intestinal enzymes or microﬂora to produce
the corresponding aglycone [14,17], which is more lipophilicAbbreviations: SGLT1, sodium glucose co-transporter 1; UDP, uridine
5 0-diphosphoglucuronic acid; UGT, uridine 50-diphosphate glucuron-
osyltransferase
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doi:10.1016/j.febslet.2005.08.060than glycosides [18,19]. Generally, when a lipophilic nutrient
is absorbed in the small intestine, its intestinal cellular metab-
olite is secreted to the interstitium as a component of chylomi-
crons. Thus, whereas hydrophilic nutrients like glucose are
mainly transported to the plasma, hydrophobic lipids are
transported into the lymph. Although analyses of plasma ﬂa-
vonoid metabolites of rodents [20] and human [21] have been
performed, it has never been investigated whether ﬂavonoids
could enter the lymph, like tocopherols, another major dietary
antioxidant [22,23]. The initial lymphatic capillaries in the gas-
trointestinal tract, into which absorbed nutrients are trans-
ported, are gathered to form a larger collecting lymph duct
and reach the thoracic lymph duct. In this study, whether quer-
cetin could be transported into the lymph was investigated
using unanesthetized thoracic lymph-cannulated rats.2. Materials and methods
2.1. Animals
Male Wistar rats (8–9-week old) were purchased from Japan SLC
Co. (Hamamatsu, Japan). The rats were allowed free access to drink-
ing water and commercial laboratory diet (Lab MR Breeder, Nosan
Co., Yokohama, Japan). The animal care and experimental procedures
followed were approved by the Committee for Animal Experimenta-
tion of the Faculty of Medicine, The University of Tokushima.
2.2. Chemicals
Authentic quercetin, sodium taurocholate and b-glucuronidase/sul-
fatase from Helix pomatia (type H-5) were obtained from Sigma
Chemical Co. (St. Louis, MO). Authentic isorhamnetin (4 0-methylated
quercetin) was purchased from Extrasynthese (Genay, France). Meth-
anol (HPLC grade) and other chemical reagents were obtained from
Kanto Chemical Co., Inc. (Tokyo, Japan).
2.3. Administration and recovery of quercetin in rats
Under anesthesia, the surgical operation of the thoracic lymph duct
cannulation for rats, along with the gastric tubing introduction for sam-
ple administration, was performed according to the procedure previ-
ously described [24]. The lymph was collected from the rats 30 min
prior to quercetin administration after an overnight recovery in restrain-
ing cages with free access to glucose–NaCl solution (25 g and 4.97 g/L,
respectively) . Then, rats were infused with 1 ml of quercetin solution in
propylene glycol (2 mg/ml, 5.9 mM) at a dose of 10 mg/kg via gastric
tubing, followed by the continuous infusion of the glucose–NaCl solu-
tion. The lymph was fractionated at 10, 20, 30, 45, 60 min and other de-
sired time points for 7 h after the quercetin infusion in glass tubes with
30 ll of 10 mM Na-EDTA solution to avoid coagulation.
2.4. Analysis of quercetin metabolites in lymph
An aliquot of the collected lymph was mixed with the same volume
of methanol/acetic acid (100:5, v/v) followed by the centrifugation at
12000 rpm for 10 min at 4 C, and the supernatant was applied toblished by Elsevier B.V. All rights reserved.
Fig. 1. Lymphatic output of quercetin metabolites in unanesthetized
lymph-cannulated rats. Rats were infused intragastrically with 2 mg
quercetin in propylene glycol/200 g body weight (n = 4). The lymph was
fractionated at 10, 20, 30, 45, 60, 90, 120, 150, 180, 240, 300, 420 min
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fatase to hydrolyze metabolized quercetin conjugates to aglycone and
isorhamnetin, as previously described [6]. Quercetin and isorhamnetin
were determined by HPLC, which were monitored with a UV detector
at 365 nm, using a C18 column, detailed elsewhere [6]. The retention
time served as a method of identiﬁcation, based on the previous con-
ﬁrmation by NMR data [20].
2.5. Determination of uridine 5 0-diphosphate glucuronosyltransferase
activity in the gastrointestinal mucosa
Uridine 5 0-diphosphate glucuronosyltransferase (UGT; EC 2.4.1.17)
activity in the gastrointestinal mucosa was measured as previously de-
scribed [25]. The rat mucosa of stomach, duodenum and jejunum were
homogenized with 0.15 M Tris–HCl buﬀer, pH 7.6, and the superna-
tant was used as the enzyme solution. Tissue enzyme preparation
was diluted 1:1 (v/v) with the Tris–HCl buﬀer containing 21 mM of
castanospermine, 20 mM MgCl2 and 2 mM DL-dithiothreitol. Then
10 lM quercetin and/or 1.25 mM uridine 5 0-diphosphoglucuronic acid
(UDP) were added to the enzyme solution and incubated at 37 C in a
shaking water bath for 30 min. The diﬀerence in quercetin content be-
tween the control without UDP and the sample incubated with UDP
was assumed to be the amount of the glucuronide conjugates. The
apparent UGT activity was expressed as pmol quercetin conjugated/
min/mg protein in the mucosa homogenate.after the administration and the concentration of each quercetin
metabolites was determined. Values are expressed as means ± S.E.M.
(n = 4).2.6. Statistics
Results are expressed as means ± S.E.M. (n = 4). A two-way ANO-
VA was used when the diﬀerence of the data among three groups was
analyzed, followed by a Bonferroni correction post hoc test. Statistical
calculation was carried out using ystat2002, an Excel Statistical
Program File (Igaku Tosho Shuppan Co., Tokyo, Japan). Data are
considered statistically signiﬁcant at P < 0.05.Fig. 2. Cumulative amount of the quercetin metabolites output in the
lymph. Rats were infused intragastrically with 2 mg quercetin in
propylene glycol/200 g body weight (n = 4). The lymph was fraction-
ated at 10, 20, 30, 45, 60, 90, 120, 150, 180, 240, 300, 420 min after the
administration and the amount of each quercetin metabolites in each
fraction was determined. Values are expressed as means ± S.E.M.
(n = 4).3. Results
3.1. Lymphatic output of the gastrointestinal metabolites of
quercetin
There was no quercetin or its related compounds detected
in the lymph before administration. The lymphatic concentra-
tion of quercetin metabolites after administration is shown in
Fig. 1. During only the ﬁrst 30 min after the quercetin injec-
tion, the intact aglycone was detected in the lymph at the
range of 0.04–0.11 lM and then became under the detection
limit (0.03 lM). The enzymatic treatment with b-glucuroni-
dase/sulfatase was performed to determine the total quercetin
glucuronides/sulfates, which are the metabolized forms pres-
ent in the plasma, resulted in increasing quercetin aglycone
released and the simultaneous detection of methylated quer-
cetin aglycone, isorhamnetin. Thus, in the lymph, quercetin
was found mostly to be conjugated with glucuronide and/or
sulfate, and partly methylated. The concentration of querce-
tin conjugates is signiﬁcantly higher than isorhamnetin conju-
gates during 180 min after the administration (P < 0.05). The
highest lymphatic concentration (Cmax) of quercetin conju-
gates at 2.54 ± 0.43 lM was found at 30 min (Tmax) after
the administration. The concentration of isorhamnetin conju-
gates was increased for 30 min and almost constant at the
range of 0.55–0.75 lM during 7 h.
The cumulative amounts of lymphatic quercetin aglycone,
its conjugates and isorhamnetin conjugates for 7 h after the
gastric administration were shown in Fig. 2. Quercetin conju-
gates were accumulated signiﬁcantly more than the aglycone
and isorhamnetin conjugates 45 min after quercetin adminis-
tration and later. The total recovery of all quercetin derivatives
was 0.44% of the administered quercetin.The initial lymph ﬂow rate for 1 h after the administration
was 3.80 ± 0.82 ml/h and became slower to 1.97 ± 0.72 ml/h
for the next 2 h. The ﬂow was stable at approximately1.6 ml/
h after that until the end of the lymph collection.
3.2. UGT activity in the upper gastrointestinal tract
The metabolic activity of the gastric mucosa was compared
with that of the intestinal mucosa since the rapid increase of
quercetin metabolites in the lymph suggested the gastric
absorption of quercetin. UGT activity was determined in this
study as the representative enzyme to produce ﬂavonoid phase
II conjugates. The apparent UGT activity was expressed as the
amount of quercetin conjugated with glucuronic acid. The
duodenal mucosa homogenate showed the highest activity
and the UGT activity in the gastric mucosa homogenate was
Fig. 3. Apparent enzymatic activity of UGT in the mucosa homog-
enates of rats. The mucosa of the stomach, duodenum and jejunum
were collected and homogenized, and the apparent UGT activity for
quercetin as the substrate was determined in those tissues. Values are
the means ± S.E.M. (n = 3). Means with diﬀerent letters are signiﬁ-
cantly diﬀerent, P < 0.05.
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The non-speciﬁc decrease of quercetin was also determined be-
cause quercetin is unstable in aqueous solution. The loss of
quercetin incubated without UDP was 17–24% and did not sig-
niﬁcantly diﬀer among three homogenates.4. Discussion
This is the ﬁrst report that quercetin is transported to the
lymph in the form of its metabolites after the administration
in the gastrointestinal tract. Generally, the gastrointestinal
lymph plays an important role in the absorption of dietary li-
pid and other lipophilic compounds. However, little is known
about whether the lymphatic pathway has any signiﬁcance in
the absorption of amphiphilic dietary compounds. The lym-
phatic proﬁle of quercetin in this study was very similar to
the plasma proﬁle in rats shown previously [26]. Thus, when
quercetin was orally administered with propylene glycol, the
Cmax of its conjugates in the blood was shown at 30 min
(Tmax), and the concentration of isorhamnetin conjugates were
increased for 1 h and became constant during 8 h. This sug-
gests that quercetin metabolites transport to both portal vein
and the lacteal. Although the mechanism about how the trans-
port pathway is chosen may be unknown, it is likely that the
composition of meal aﬀects the pathway. When a-tocopherol,
a lipophilic dietary antioxidant, is absorbed, its micellar condi-
tion in the intestinal lumen is important in enhancing the
absorption in the intestine [22]. Because ﬂavonoids are
amphiphilic, the aqueous solubility of quercetin also aﬀects
its bioavailability. Azuma et al. [27,28] reported that the co-
administration of lipids and emulsiﬁers enhances the intestinal
absorption of quercetin in rats. Furthermore, Lesser et al. [29]
showed that high-fat diet enhances the absorption of quercetin
in pigs. Thus, lipids have been considered to increase the solu-
bility of quercetin in the intestinal ﬂuid and enhance the up-
take into the enterocyte. The result of this study showing
that quercetin metabolites appeared in the lymph suggests that
quercetin administered with lipids could be easily transferredto the lacteal in the small intestine. When the same dose of
quercetin as in this study was administered to rats, the maxi-
mum plasma concentration at 1 h was reported to be 9.6 lM
of quercetin metabolites and 4.2 lM of isorhamnetin metabo-
lites [30], which were higher than the lymphatic concentration
in this study (2.5 and 0.6 lM, respectively). In both cases,
quercetin was administered with propylene glycol. These re-
sults imply the preferential distribution of quercetin metabo-
lites to the blood on this condition. Alternatively, the
lymphatic concentration may be increased when quercetin is
administered with dietary lipids. Recently, de Boer et al. [9] re-
ported the tissue distribution of quercetin metabolites in rats
fed quercetin for 11 weeks. Interestingly, quercetin was accu-
mulated at the highest amount in the lung. Our ﬁndings show-
ing the presence of quercetin in the thoracic lymph may
provide a potential mechanism by which quercetin metabolites
can be found in the lung at these concentrations.
The maximum concentration of quercetin metabolites
appearing in the lymph was as rapid as 30 min after the admin-
istration. Crespy et al. [8] previously showed the possibility of
quercetin absorption via the stomach when it was administered
as its aglycone form. The phase II conjugation activity of the
upper gastrointestinal mucosa was investigated in this study
since quercetin was mainly converted to its glucuronide/sulfate
conjugates. It has been previously reported that the main con-
jugation enzyme in rat intestinal mucosa was UGT, and sulfa-
tion only takes place in the liver [25]. We found that the gastric
mucosa does possess UGT activity. However, the highest activ-
ity was obtained from the duodenal mucosa, followed by the
jejunal mucosa. Shelby et al. [31] reported the mRNA expres-
sion of rat UGT family in the gastrointestinal tract. The similar
expression levels of UGT1A1, a major UGT isoform in multi-
ple tissues, were shown in stomach, duodenum, and jejunum,
whereas several minor isoforms were expressed at higher level
in duodenum and jejunum than in stomach. Quercetin has ﬁve
hydroxyl groups, and the diﬀerent regioselectivity of glucuron-
idation is shown by the various UGT isoforms [32]. The diﬀer-
ence of the activity among these tissues may depend on the
distinctive expression of UGT isoforms. In practice, dietary
quercetin is present as its glycosides in plant food, which cannot
be absorbed in the stomach [8]. Thus, with dietary exposure,
even though a part of quercetin could be absorbed from the
stomach like shown in this study, the main organ for the quer-
cetin uptake is probably the upper small intestine.
In conclusion, this result indicates the presence of a novel
ﬂavonoid transport pathway, at least in part, from the gastro-
intestinal mucosa to the circulation, that is, not direct inﬂux
into the portal vein but via the lymphatic pathway. Although
the signiﬁcance of the alternative pathways is currently un-
known, this ﬁnding will give new ideas for the bioavailability
and key target tissues of dietary ﬂavonoids.
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